중동 및 아프리카 생물공정 시장 전망 2031년 - 지역 분석 - 제품별(기기 및 소모품 및 액세서리), 운영 규모(상업 운영 및 임상 운영), 공정(하류 생물공정 및 상류 생물공정), 응용 분야(단일클론 항체, 백신, 재조합 단백질, 세포 및 유전자 치료 및 기타), 최종 사용자(생물제약 회사, 계약 제조 기관 및 기타)
자동화된 세포 치료 제조로의 전환이 중동 및 아프리카 생물공정 시장을 강화합니다.
세포 치료의 수가 증가함에 따라 세포 치료 제품의 생산이 전 세계적으로 소량에서 대량으로 전환되었습니다. 세포 치료에 대한 연구 활동이 증가함에 따라 고급 제조 솔루션에 대한 수요가 증가했습니다. 이를 감안하여 많은 기업이 학계 연구원과 대형 생명공학 회사의 요구를 충족하는 제품을 제공하고 있습니다. 예를 들어 Miltenyi의 Lonza Cocoon과 CliniMACS Prodigy 시스템은 단일 시스템 내에서 CAR-T 프로세스의 대부분 순차적 단위 작업을 자동화할 수 있도록 설계되었습니다. 또한, 학문적, 임상적 환경에서 대량 생산 및 상용화로 세포 치료의 진화는 제조 자동화에 대한 수요를 증가시키고 있습니다. 2019년 5월, GE Healthcare는 전체 세포 치료 워크플로를 지원하는 Chronicle 웹 애플리케이션을 출시했습니다. Chronicle 자동화 소프트웨어는 복잡한 세포 치료 공정 개발 및 제조를 최적화하도록 설계된 GMP(Good Manufacturing Practice)를 준수하는 디지털 솔루션입니다. 기업들은 또한 세포 치료 자동화를 위한 전략적 및 기술적 개발에 착수하고 있습니다. 예를 들어, 2020년 7월, Thermo Fisher Scientific Inc.와 Lyell Immunopharma는 암 환자를 위한 효과적인 세포 치료를 설계하는 공정을 개발하고 제조하기 위해 협력했습니다. 이 협력에 따라, 두 회사는 T 세포의 적합성을 개선하고 시약, 소모품 및 기구와 함께 통합 cGMP 준수 플랫폼(시스템 및 소프트웨어)의 개발을 지원하는 것을 목표로 합니다. 2019년 3월, Lonza는 이스라엘의 Sheba Medical Center와 협력하여 자사의 진료소 Cocoon 세포 치료 제조 플랫폼을 사용하여 자동화되고 폐쇄된 CAR-T 제조를 제공했습니다. 자동화된 절차는 생산 비용을 대폭 절감하고 직원 생산성과 유지율을 향상시킬 수 있습니다. 이러한 요소 외에도 자동화된 프로세스는 제조 단위에서 다양한 오염원을 제한하고 결국 프로세스 일관성을 향상시켜 수동 오류를 줄여 전반적으로 우수한 품질의 제품을 생산합니다. 따라서 세포 치료 제조업체에서 자동화를 점점 더 많이 도입하고 세포 치료 분야에서 제품 혁신이 증가함에 따라 세포 치료 생물 처리 또는 제조가 촉진될 가능성이 높습니다.
중동 및 아프리카 생물 처리 시장 개요
중동 및 아프리카 생물 처리 시장은 사우디 아라비아, UAE, 남아프리카 공화국, 그리고 중동 및 아프리카의 나머지 지역으로 세분화됩니다. 사우디 아라비아는 중동 및 아프리카에서 가장 큰 시장 점유율을 차지합니다. 암 유병률 증가, 면역 질환 발생률 증가, 정부의 호의적인 이니셔티브, 연구 개발 활동의 급증은 이 지역 시장을 주도하는 몇 가지 요인입니다. 사우디 아라비아 부처는 바이오 기술 회사와 계약을 체결하여 해당 국가에 생산 시설을 설립하고 있습니다. 이에 따라 중동 및 아프리카에서 입지를 강화하기 위해 국제 기업이 채택한 확장 전략은 향후 몇 년 동안 생물 처리 시장에 도움이 될 것으로 예상됩니다.
중동 및 아프리카 생물 처리 시장 수익 및 2031년 예측(백만 달러)
중동 및 아프리카 생물 처리 시장 세분화
중동 및 아프리카 생물 처리 시장은 제품, 운영 규모, 프로세스, 응용 프로그램, 최종 사용자 및 국가로 분류됩니다.
제품을 기준으로 중동 및 아프리카 생물 처리 시장은 기기와 소모품 및 액세서리로 나뉩니다. 기기 세그먼트는 2023년에 더 큰 시장 점유율을 차지했습니다. 또한 기기 세그먼트는 여과 장치, 생물 반응기, 크로마토그래피 시스템, 원심 분리기, 건조 장치 등으로 세분화됩니다. 또한 생물 반응기 하위 세그먼트는 파일럿 규모, 전체 규모 및 실험실 규모로 분류됩니다. 또한 하위 세그먼트 크로마토그래피 시스템은 액체 크로마토그래피, 가스 크로마토그래피 및 기타로 세분화됩니다. 또한 소모품 및 액세서리 세그먼트는 시약, 세포 배양 배지, 크로마토그래피 수지 및 기타로 세분화됩니다.
운영 규모 측면에서 중동 및 아프리카 바이오 프로세싱 시장은 상업적 운영과 임상 운영으로 나뉩니다. 상업적 운영 세그먼트는 2023년에 더 큰 시장 점유율을 차지했습니다.
프로세스별로 중동 및 아프리카 바이오 프로세싱 시장은 하류 바이오 프로세스와 상류 바이오 프로세스로 나뉩니다. 하류 바이오 프로세스 세그먼트는 2023년에 더 큰 시장 점유율을 차지했습니다.
응용 프로그램을 기준으로 중동 및 아프리카 바이오 프로세싱 시장은 단일 클론 항체, 백신, 재조합 단백질, 세포 및 유전자 치료 및 기타로 분류됩니다. 단일클론 항체 세그먼트는 2023년에 가장 큰 시장 점유율을 차지했습니다.
최종 사용자 측면에서 중동 및 아프리카 바이오프로세싱 시장은 바이오제약 회사, 계약 제조 기관 및 기타로 분류됩니다. 바이오제약 회사 세그먼트는 2023년에 가장 큰 시장 점유율을 차지했습니다.
국가별로 중동 및 아프리카 바이오프로세싱 시장은 사우디아라비아, 남아프리카, UAE 및 기타 중동 및 아프리카로 세분화됩니다. 사우디아라비아는 2023년에 중동 및 아프리카 바이오프로세싱 시장 점유율을 지배했습니다.
Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Agilent Technologies Inc 및 Cytiva US LLC는 중동 및 아프리카 바이오프로세싱 시장에서 운영되는 일부 선도 기업입니다.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodologys
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Bioprocessing Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Increasing Prevalence of Chronic Diseases
4.1.2 Growing Biopharmaceutical Industry
4.2 Market Restraints
4.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
4.3 Market Opportunities
4.3.1 Proliferating Demand for Personalized Medicine
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact of Drivers and Restraints:
5. Bioprocessing Market - Middle East & Africa Analysis
5.1 Middle East & Africa Bioprocessing Market Overview
5.2 Bioprocessing Market Revenue (US$ Million), 2021-2031
6. Middle East & Africa Bioprocessing Market Analysis - by Product
6.1 Overview
6.2 Instruments
6.2.1 Overview
6.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
6.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
6.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
6.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
6.3 Consumables & Accessories
6.3.1 Overview
6.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
6.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
7. Middle East & Africa Bioprocessing Market Analysis - by Scale of Operation
7.1 Overview
7.2 Commercial Operations
7.2.1 Overview
7.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Clinical Operations
7.3.1 Overview
7.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8. Middle East & Africa Bioprocessing Market Analysis - by Process
8.1 Overview
8.2 Downstream Bioprocess
8.2.1 Overview
8.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Upstream Bioprocess
8.3.1 Overview
8.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9. Middle East & Africa Bioprocessing Market Analysis - by Application
9.1 Overview
9.2 Monoclonal Antibodies
9.2.1 Overview
9.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Vaccines
9.3.1 Overview
9.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Recombinant Protein
9.4.1 Overview
9.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Cell & Gene Therapy
9.5.1 Overview
9.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10. Middle East & Africa Bioprocessing Market Analysis - by End User
10.1 Overview
10.2 Biopharmaceutical Companies
10.2.1 Overview
10.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Contract Manufacturing Organization
10.3.1 Overview
10.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Others
10.4.1 Overview
10.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11. Middle East & Africa Bioprocessing Market - Country Analysis
11.1 Middle East & Africa
11.1.1 Middle East & Africa: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
11.1.1.1 Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.1.1 Overview
11.1.1.2 Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.2.1 Saudi Arabia: Bioprocessing Market Breakdown, by Product
11.1.1.2.1.1 Saudi Arabia: Bioprocessing Market Breakdown, by Instruments
11.1.1.2.1.1.1 Saudi Arabia: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.2.1.1.2 Saudi Arabia: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.2.1.2 Saudi Arabia: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.2.2 Saudi Arabia: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.2.3 Saudi Arabia: Bioprocessing Market Breakdown, by Process
11.1.1.2.4 Saudi Arabia: Bioprocessing Market Breakdown, by Application
11.1.1.2.5 Saudi Arabia: Bioprocessing Market Breakdown, by End User
11.1.1.3 South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.3.1 Overview
11.1.1.4 South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.4.1 South Africa: Bioprocessing Market Breakdown, by Product
11.1.1.4.1.1 South Africa: Bioprocessing Market Breakdown, by Instruments
11.1.1.4.1.1.1 South Africa: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.4.1.1.2 South Africa: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.4.1.2 South Africa: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.4.2 South Africa: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.4.3 South Africa: Bioprocessing Market Breakdown, by Process
11.1.1.4.4 South Africa: Bioprocessing Market Breakdown, by Application
11.1.1.4.5 South Africa: Bioprocessing Market Breakdown, by End User
11.1.1.5 United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.5.1 Overview
11.1.1.6 United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.6.1 United Arab Emirates: Bioprocessing Market Breakdown, by Product
11.1.1.6.1.1 United Arab Emirates: Bioprocessing Market Breakdown, by Instruments
11.1.1.6.1.1.1 United Arab Emirates: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.6.1.1.2 United Arab Emirates: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.6.1.2 United Arab Emirates: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.6.2 United Arab Emirates: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.6.3 United Arab Emirates: Bioprocessing Market Breakdown, by Process
11.1.1.6.4 United Arab Emirates: Bioprocessing Market Breakdown, by Application
11.1.1.6.5 United Arab Emirates: Bioprocessing Market Breakdown, by End User
11.1.1.7 Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.7.1 Overview
11.1.1.8 Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.8.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Product
11.1.1.8.1.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Instruments
11.1.1.8.1.1.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.8.1.1.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.8.1.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.8.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.8.3 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Process
11.1.1.8.4 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Application
11.1.1.8.5 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Bioprocessing Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Getinge AB
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Sartorius AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Corning Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bio-Rad Laboratories Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Merck KGaA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 3M Co
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Eppendorf SE
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Agilent Technologies Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Cytiva US LLC
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
?
List of Tables
Table 1. Middle East & Africa Bioprocessing Market Segmentation
Table 2. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
Table 6. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 7. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 8. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 9. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 10. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 11. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 12. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 13. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 14. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 15. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 16. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 17. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 18. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 19. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 20. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 21. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 22. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 23. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 24. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 25. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 26. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 27. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 28. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 29. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 30. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 31. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 32. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 33. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 34. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 35. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 36. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 37. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 38. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 39. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 40. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 41. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 42. Recent Inorganic Growth Strategies in the Bioprocessing Market
Table 43. Recent Organic Growth Strategies in the Bioprocessing Market
Table 44. Glossary of Terms, Bioprocessing Market
?
List of Figures
Figure 1. Middle East & Africa Bioprocessing Market Segmentation, by Country
Figure 2. Bioprocessing Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031
Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)
Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)
Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)
Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)
Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)
Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Middle East & Africa: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)
Figure 25. Middle East & Africa: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 30. Growth Strategies in the Bioprocessing Market
- Getinge AB
- Thermo Fisher Scientific Inc
- Sartorius AG
- Corning Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- 3M Co
- Eppendorf SE
- Agilent Technologies Inc
- Cytiva US LLC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa bioprocessing market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa bioprocessing market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.